)
Moon Lee, PhD
BD Manager
Shaperon Inc
Moon Lee, PhD, is Business Development Manager at Shaperon Inc., a clinical-stage Korean biotech listed on KOSDAQ. Shaperon is developing an inflammasome modulator platform targeting the GPCR19–P2X7–NLRP3 axis, with small-molecule programs in atopic dermatitis (NuGel), diabetic foot ulcer (NuDifin), idiopathic pulmonary fibrosis (NuPulin), and Alzheimer's disease (NuCerin), alongside Shaperon's NanoMab (nanobody) platform, focused on oncology with an ongoing collaboration in infectious disease.
As part of Shaperon's BD team, Moon supports the company's global partnering activities across the US, EU, Greater China, Japan, and Russia/CIS. She holds a PhD in cancer immunology from the University of Helsinki and works closely with Shaperon's R&D and executive leadership on license-out, investment, and co-development opportunities across the pipeline.
Sessions
-
24-Jun-2026Theater 4Shaperon Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}